For the Quarter Ending June 2026
Cephalexin Prices in North America
- In the USA, the Cephalexin Price Index rose by 18.29% quarter-over-quarter, driven by tighter upstream intermediates.
- The average Cephalexin price for the quarter was approximately USD 63300.00/MT, CFR Houston basis in Q2 2026.
- Cephalexin Spot Price softened in June; larger import lots eased tightness, lowering the Price Index.
- Cephalexin Price Forecast anticipates a rebound in July as restocking occurs, supporting CFR Houston offers.
- Cephalexin Production Cost Trend remained elevated due to constrained 7-ADCA availability and increased compliance expenses.
- Cephalexin Demand Outlook stays steady across human and veterinary sectors, underpinning sustained distributor procurement activity.
- Inventories at Houston improved, pressuring the Cephalexin Price Index and constraining regional export demand premiums.
- Indian and Spanish suppliers maintained production, increasing competition and pressuring Cephalexin Spot Price and supplier margins.
Why did the price of Cephalexin change in June 2026 in North America?
- Larger import lots from India and China cleared, increasing availability and creating downward pressure on spot offers.
- Prescription volumes moderated seasonally while pharmacy benefit manager rebate pressure compressed distributor margins, limiting price resilience.
- Stable shipping and additional generic approvals increased competition, while FDA approvals broadened the supplier pool, lowering landed cost dynamics.
Cephalexin Prices in APAC
- In China, the Cephalexin Price Index rose by 18.2875% quarter-over-quarter, driven by tightened export-driven supply.
- The average Cephalexin price for the quarter was approximately USD 63086.67/MT per Shanghai FOB data
- Cephalexin Spot Price softened in June as inventories rose and overseas restocking activity paused modestly
- Cephalexin Price Forecast anticipates slight recovery post-June as maintenance and seasonal procurement lift export demand
- Cephalexin Production Cost Trend remains elevated as coal-based utilities increase steam and solvent recovery expenses
- Cephalexin Demand Outlook is stable as export tenders sustain orders while domestic procurement remains muted
- Cephalexin Price Index eased in June as producers cleared inventories and offered discounts to move
- Export inventories were comfortable but thinning, prompting sellers to prioritize overseas parcels and uphold offers
Why did the price of Cephalexin change in June 2026 in APAC?
- Intensified environmental inspections reduced operating days at fermentation sites, tightening spot availability and raising offers
- Higher coal-based steam and electricity tariffs increased conversion costs, enabling producers to pass elevated offers
- Rerouting shipments around the Cape extended times and increased freight premiums, elevating exporters' landed costs
India
- In India, the Cephalexin Price Index rose by 16.08% quarter-over-quarter, driven by higher 7-ACA costs.
- Cephalexin Spot Price softened in June as Chinese 7-ACA quotations eased and container availability improved.
Cephalexin Prices in Europe
- In Germany, the Cephalexin Price Index rose by 18.29% quarter-over-quarter, reflecting upstream cost pass-through and lean inventories.
- The average Cephalexin price for the quarter was approximately USD 63233.33/MT, supporting elevated landed cost trends.
- Competitive Asian offers pressured the Cephalexin Spot Price as exporters adjusted FOBs amid ample export allocations.
- The Cephalexin Price Forecast indicates modest corrections in June followed by gradual recovery driven by restocking activity.
- Rising 7-ADCA fermentation costs elevated the Cephalexin Production Cost Trend, prompting exporters to pass through higher offers.
- Cephalexin Demand Outlook remains steady with hospital and retail prescriptions supporting routine volumes, limiting abrupt demand spikes.
- Wholesaler inventories remained lean, amplifying the Cephalexin Price Index sensitivity to freight and audit-related supply disruptions.
- Operational GMP audits in India constrained the supplier pool, tightening spot availability and supporting elevated landed Cephalexin offers.
Why did the price of Cephalexin change in June 2026 in Europe?
- Abundant Asian export offers and steady Indian production increased available volumes, pressuring landed import quotations lower.
- Higher 7-ADCA fermentation input costs and elevated freight insurance increased landed costs, partly offsetting downward pressure.
- Lean wholesaler inventories and muted tender activity reduced immediate buying, enabling buyers to negotiate modest price concessions.
For the Quarter Ending March 2026
Cephalexin Prices in APAC
- In China, the Cephalexin Price Index rose by 3.86% quarter-over-quarter, supported by stronger export demand.
- The average Cephalexin price for the quarter was approximately USD 53333.33/MT, reflecting modest export-weighted levels.
- Cephalexin Spot Price movements remained contained while the Price Index reflected month-end tightening at ports.
- Cephalexin Price Forecast indicates moderate gains into April as restocking and tender schedules support upward revisions.
- Cephalexin Production Cost Trend rose due to higher coal-fired steam tariffs and wastewater-treatment compliance costs.
- Cephalexin Demand Outlook remains export-led with Indian, Brazilian, and Indonesian tenders sustaining incremental procurement volumes.
- Cephalexin Price Index gains were amplified by constrained merchant availability and pre-announced maintenance, reducing spot offers.
- Inventories stayed around two weeks cover while vertically integrated producers maintained near-nameplate operating rates this quarter.
Why did the price of Cephalexin change in March 2026 in APAC?
- Constrained merchant availability and GMP recertification batches limited spot offers, tightening short-term exportable supply levels.
- Robust public-sector tendering from India, Brazil, and Indonesia increased replacement buying, supporting stronger export-driven pricing.
- Higher coal-fired steam tariffs and wastewater-treatment fees added cost-push pressure to producers' cash-cost bases modestly.
Cephalexin Prices in Europe
- In Germany, the Cephalexin Price Index rose by 3.89% quarter-over-quarter, reflecting tighter Asian export offers.
- The average Cephalexin price for the quarter was approximately USD 53458.00/MT, reported by Hamburg importers.
- Reduced export availability pushed Cephalexin Spot Price higher, tightening German wholesaler inventories and prompting buying.
- Cephalexin Price Forecast indicates modest gains as importers cover lean stocks ahead of spring production.
- Rising energy and fermentation inputs supported an uptick in Cephalexin Production Cost Trend for exporting manufacturers.
- German hospital tenders and retail prescriptions strengthened Cephalexin Demand Outlook in March, sustaining import pull.
- Wholesaler stock rebuilding and tender schedules lifted the Cephalexin Price Index, accentuating short-term market tightness.
- Asian plant maintenance, allocation discipline constrained supplies, pressuring landed cost,s and strengthening German buying urgency.
Why did the price of Cephalexin change in March 2026 in Europe?
- Reduced Asian spot parcels and one inspection-delayed release materially tightened availability for Hamburg importers urgently.
- Pharmacy and hospital restocking ahead of spring tenders amplified buying, sustaining price upside in March.
- Higher energy-linked fermentation costs and elevated freight plus war-risk insurance supported landed cost increases notably.
Cephalexin Prices in North America
- In the USA, the Cephalexin Price Index rose by 3.84% quarter-over-quarter, reflecting tighter imports and compliance.
- The average Cephalexin price for the quarter was approximately USD 53512.00/MT, reflecting logistics and compliance.
- Cephalexin Spot Price held steady; the Price Index showed volatility amid ample imports and inventory
- Cephalexin Price Forecast expects gains as the Cephalexin Production Cost Trend firmed from feedstock increases
- Cephalexin Demand Outlook remains positive with hospital and retail prescriptions supporting replenishment and distributor buying
- March Cephalexin Price Index rose as exporters tightened allocations and U.S. distributors replenished inventories seasonally
- Higher war-risk insurance and freight elevated landed costs, reinforcing the Cephalexin Production Cost Trend, and offers
- Market liquidity remained adequate, limiting volatility; the Cephalexin Price Forecast assumes stable imports and buying
Why did the price of Cephalexin change in March 2026 in North America?
- Tighter export allocations from India and Europe reduced import availability, driving higher landed costs in March
- Firm 7-ADCA feedstock prices and higher compliance expenses raised Cephalexin Production Cost Trend and offers
- U.S. distributors accelerated replenishment for seasonal demand and formulary updates, tightening inventories and firming pricing
For the Quarter Ending December 2025
Cephalexin Price in APAC
- In China, the Cephalexin Price Index rose by 0.51% quarter-over-quarter, mildly reflecting post-holiday restocking activity.
- The average Cephalexin price for the quarter was approximately USD 51351.33/MT, reflecting inventory normalization nationally.
- Cephalexin Spot Price firmed slightly as hospitals and formulators replenished stocks amid seasonal respiratory prescriptions.
- Cephalexin Price Forecast shows modest upside into Q1 driven by restocking and supplier inventory management.
- Cephalexin Production Cost Trend remained muted as intermediates and coal-linked utility tariffs held broadly unchanged.
- Cephalexin Demand Outlook improved modestly with year-end tenders and steady export enquiries supporting additional offtake.
- Logistics stability and integrated feedstock supply helped stabilize the Cephalexin Price Index during December shipments.
- Producers maintained high operating rates, enabling shipments and limiting volatility in the Cephalexin Price Index.
Why did the price of Cephalexin change in December 2025 in APAC?
- Export enquiries firmed before year-end tenders, increasing short-term offtake and slightly narrowing spot availability overall.
- Upstream feedstock flows remained uninterrupted and input pricing stable, preventing significant production cost increases during.
- Shanghai port operations and inland logistics normalized, enabling timely shipments and avoiding supply-side disruptions to prices.
Cephalexin Price in Europe
- In Germany, the Cephalexin Price Index rose by 0.5% quarter-over-quarter, due to marginally firmer Indian-origin offers and lean wholesaler inventories.
- The average Cephalexin price for the quarter was approximately USD 55323.33/MT, reflecting marginal firmness across import sources.
- German Cephalexin Spot Price activity stayed narrow, with limited volatility amid steady Asian export flows and logistics relief.
- Cephalexin Price Forecast indicates modest month-to-month gains supported by year-end procurement and controlled supply tightness.
- Cephalexin Production Cost Trend shows upward pressure from feedstock and container handling, partially offset by stable freight rates.
- Cephalexin Demand Outlook remains steady, driven by hospital and outpatient procurement but constrained by rebate-driven purchasing behaviors.
- Cephalexin Price Index movements reflected balanced inventories, efficient Hamburg operations, and mixed currency effects on landed costs.
- Export redistribution to neighbors and absence of disruptions maintained market continuity, keeping offers cautiously firm across the quarter.
Why did the price of Cephalexin change in December 2025 in Europe?
- Marginally higher Indian-origin offers combined with lean wholesaler inventories nudged landed costs higher in December.
- Container booking costs ticked up slightly, increasing delivered cost base despite broadly stable freight rates.
- Statutory rebate ceilings limited pass-through, tempering stronger price increases despite modest supply tightening in Germany.
Cephalexin Price in North America
- In USA, the Cephalexin Price Index rose by 0.62% quarter-over-quarter, procurement and tighter European allocations.
- The average Cephalexin price for the quarter was approximately USD 55375.00/MT, per major distributors' averages.
- Cephalexin Spot Price remained thin as distributors replenished lower inventories, keeping Cephalexin Price Index stable.
- Cephalexin Price Forecast indicates modest upside into early 2026 driven by seasonality and restocking activity.
- Cephalexin Production Cost Trend reflected higher Asian offers for feedstock and freight driving upward pressure.
- Cephalexin Demand Outlook remains broadly constructive with winter prescribing and veterinary restocking underpinning procurement activity.
- Lower trans-Pacific freight and stable currency reduced landed costs, yet Cephalexin Price Index preserved firmness.
- European allocation discipline and four-to-six week lead times tightened offers, influencing Cephalexin Spot Price availability.
Why did the price of Cephalexin change in December 2025 in North America?
- Tighter European export allocations and purchasing increased landed costs, reducing spot cargoes to US importers.
- Freight easing offset offers, but higher Asian feedstock quotations and allocation raised import pricing pressure.
- Steady winter prescription volumes and distributor restocking depleted inventories, supporting modest price gains through December.
For the Quarter Ending September 2025
North America
- In USA, the Cephalexin Price Index rose by 0.15% quarter-over-quarter, reflecting import costs and demand.
- The average Cephalexin price for the quarter was approximately USD 55031.67/MT, per official trade records.
- Elevated freight and currency moves constrained Cephalexin Spot Price while Cephalexin Price Index remained supportive.
- Declining landed costs yet persistent feedstock inflation moderated the Cephalexin Production Cost Trend and margins.
- Cephalexin Demand Outlook shows cautious restocking from API manufacturers due to elevated inventories and uncertainty.
- Short term Cephalexin Price Forecast suggests gradual softening then selective rebounds from year-end procurement activity.
- High domestic stocks depressed the Cephalexin Price Index while export enquiries provided intermittent support periodically.
- Major manufacturer run-rates remained stable, limiting supply shocks and keeping the Cephalexin Price Index rangebound.
Why did the price of Cephalexin change in September 2025 in North America?
- Higher European export offers and freight increases raised landed costs, tightening importer margins, pressuring prices.
- Elevated inventory levels and cautious restocking by downstream API formulators reduced buying urgency, softening demand.
- Currency fluctuations and easing freight rates altered procurement economics, creating mixed incentives across importers nationwide.
APAC
- In China, the Cephalexin Price Index rose by 0.14% quarter-over-quarter, reflecting supply and mixed demand.
- The average Cephalexin price for the quarter was approximately USD 54910.00/MT, reflecting market settlement levels.
- Cephalexin Spot Price eased as suppliers cleared inventories, pressuring offers despite stable production and logistics.
- Cephalexin Price Forecast indicates modest upside later in quarter supported by restocking and seasonal uptick.
- Rising raw material costs altered the Cephalexin Production Cost Trend, constraining price flexibility for exporters.
- Weak overseas orders shaped the Cephalexin Demand Outlook, while domestic pharmaceutical offtake remained comparatively steady.
- High inventories and stock clearance pressured the Cephalexin Price Index, constraining export quotations and margins.
- Stable plant operations and strategic restocking influenced offers, prompting analysts to revise the Cephalexin Price Index trajectory.
Why did the price of Cephalexin change in September 2025 in APAC?
- Production restarts increased availability after shutdowns, raising inventories and moderating spot differentials and export urgency.
- Continued raw material cost pressures and currency shifts influenced supplier margins, sustaining cautious pricing adjustments in September.
- Subdued overseas demand and accelerated domestic stock clearance reduced procurement activity, applying downward pressure on quotations.
Europe
- In Germany, the Cephalexin Price Index rose by 0.15% quarter-over-quarter, reflecting modest import and demand shifts.
- The average Cephalexin price for the quarter was approximately USD 55014.67/MT, according to CFR Hamburg data.
- Cephalexin Spot Price softened in August, pressured by ample inventories and lower Asian export quotations.
- Cephalexin Demand Outlook remained muted as API and healthcare formulators delayed restocking amid cautious procurement behavior.
- Cephalexin Production Cost Trend showed mixed signals with freight inflation offset by declining raw material costs.
- Cephalexin Price Forecast indicates modest volatility into autumn, balancing intermittent restocking against persistent inventory overhangs.
- Cephalexin Price Index movements tracked maritime freight fluctuations and Asian exporters' pricing strategies affecting landed costs.
- Domestic inventories remained elevated, limiting purchase urgency while export demand intermittently supported supplier price resilience.
Why did the price of Cephalexin change in September 2025 in Europe?
- Asian exporters moderated quotations while German buyers retained high inventories, softening procurement and price momentum.
- Freight volatility affected landed costs, creating import economics uncertainty that pressured pricing for German buyers.
- Mixed API and healthcare offtake tempered restocking decisions, limiting immediate buying despite improving manufacturing indicators.
